CHU dijon Bourgogne
Dijon, 21079, France
NCT Number: NCT03215446
Halogenated anaesthetic agents (HAA) may induce protective processes by pre-conditioning the myocardium. All of the literature shows that HAA induce pre-conditioning, thanks to a class effect, and Sevoflurane is the most widely used today.
In humans, the protective effects of halogenated agents have principally been studied in heart surgery and have shown encouraging clinical results. It seems that HAA induce both pre-conditioning of the myocardium (early and late) and post conditioning.
Given these protective effects of HAA, in 2007, the American Heart Association (AHA) recommended the use of HAA for anaesthesia maintenance in non-cardiac surgery in patients with a high cardio-vascular risk. The aim of this study is to show a decrease in rhabdomyolysis and tissue distress (kidneys, myocardium and liver), thanks to Sevoflurane anaesthesia, in the post-operative period following vascular surgery with clamping
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Dijon, 21079, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 24 hours post surgery
Centre Hospitalier Universitaire Dijon
Other
Evaluation of Total (Pre and Post) Conditioning on Rhabdomyolysis of Sedation With Sevoflurane Versus Propofol in Vascular Surgery With Clamping
Acronym: PHAR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03681834
Vascular Surgery
Dijon, France
View Trial DetailsNCT04169217
Vascular Surgery
London, United Kingdom
View Trial DetailsNCT04137991
Cardiac Surgery, General Anesthesia
Brussels, Belgium
View Trial DetailsNCT01558596
Arterial Occlusive Diseases, Arteriosclerosis
Minneapolis, Minnesota, United States
View Trial Details